Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BioKid
- Development stage
- Unknown
- Lead developer
- Takgene
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
**BioKid** is an oral probiotic supplement developed by Takgene (Takgene Pharma) specifically formulated for children's digestive and immune health. The active ingredient in BioKid is the beneficial bacterium *Bifidobacterium animalis subsp. lactis* (often referred to as *Bifidobacterium lactis*), delivered in a sachet formulation containing $1 \times 10^9$ CFU. BioKid works by colonizing the gastrointestinal tract, modulating the gut microflora, promoting immunoglobulin A (IgA) production, and regulating the Treg/Th17 immune balance. It is approved and marketed for the prevention and treatment of various pediatric gastrointestinal and immune-related conditions, including antibiotic-associated diarrhea, infectious diarrhea, gastroenteritis, general gastrointestinal problems, and food allergies in children.
- Brand names
- BioKid
- Other names
- BioKid ProbioticBioKid sachet
Beyond the preview
Go deeper on BioKid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioKid.